Collaborative R&D agreement for early-stage diabetes researchCollaborative R&d Agreement • March 28th, 2022
Contract Type FiledMarch 28th, 2022The European Foundation for the Study of Diabetes (EFSD), JDRF and Eli Lilly and Company (NYSE: LLY) have agreed to extend their collaboration for the European Programme in Type 1 Diabetes Research through 2020.